Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Weight Loss 2Polyps 2Hyperplasia 2Stomach Neoplasms 1Psoriasis 1Osteoarthritis 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1alovudine 1Tirzepatide 1Restraint, Physical 1Microspheres 1Metformin 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hyperplasia × Eicosapentaenoic Acid × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡